𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tacrolimus: a new immunosuppressant for steroid refractory inflammatory bowel disease

✍ Scribed by K Fellermann; K.R Herrlinger; T Witthoeft; N Homann; D Ludwig; E.F Stange

Book ID
117230935
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
61 KB
Volume
33
Category
Article
ISSN
0041-1345

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

New steroids for inflammatory bowel dise
New steroids for inflammatory bowel disease
✍ Dr. Robert LΓΆfberg πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 700 KB

The antiinflammatory effects of glucocorticosteroids (GCS) in inflammatory bowel disease (IBD) are unsurpassed by those of any other type of drug, but the beneficial effects are often offset by troublesome, and sometimes irreversible, systemic side effects. Improved GCS have been developed with the

Medium-term results of oral tacrolimus t
Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease
✍ Siew C. Ng; Naila Arebi; Michael A. Kamm πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 86 KB πŸ‘ 2 views

## Background: This study aimed to evaluate the efficacy of oral tacrolimus in patients with inflammatory bowel disease (ibd) refractory to conventional therapy, including azathioprine, 6-mercaptopurine, and infliximab. ## Methods: Retrospective review of all patients with ibd treated with oral t

Mycophenolate mofetil therapy for refrac
Mycophenolate mofetil therapy for refractory inflammatory bowel disease
✍ S. Palaniappan; A. C. Ford; D. Greer; S. M. Everett; D. M. Chalmers; A. T. R. Ax πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 78 KB

Background: Mycophenolate mofetil (MMF) is an immunomodulatory drug, and its use in inflammatory bowel disease has previously been reported. The aim of this study was to review the Leeds Colitis Clinic experience of the safety and efficacy of MMF in treating patients with refractory Crohn's disease